1.25
Bionano Genomics Inc (BNGO) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Revenues |
22.19%
8.171
|
6.687 | 7.951 | 7.367 | 6.733 |
| Cost Of Revenue |
12.29%
3.857
|
3.435 | 4.552 | 3.997 | 3.256 |
|
|
6.67%
8.544
|
8.01 | 8.706 | - | - |
| Costs And Expenses |
3.44%
11.53
|
11.15 | 11.94 | 11.91 | 11.28 |
| Operating Income/Loss |
8.60%
-7.218
|
-7.897 | -8.536 | -8.538 | -7.80 |
| Nonoperating Income/Loss |
50.00%
-0.198
|
-0.396 | 0.638 | 0.049 | 0.953 |
| Income/Loss From Continuing Operations Before Tax |
10.58%
-7.416
|
-8.293 | -7.898 | -8.489 | -6.847 |
| Income Tax Expense/Benefit |
30.00%
0.007
|
0.01 | 0.035 | 0.014 | 0.01 |
| Net Income/Loss |
10.60%
-7.423
|
-8.303 | -7.933 | -8.503 | -6.857 |
| Basic Average Shares |
5.16%
11.55
|
10.98 | - | 5.338 | 3.441 |
| Diluted Average Shares |
5.16%
11.55
|
10.98 | - | 5.338 | 3.441 |
| Basic Earnings Per Share |
15.79%
-0.64
|
-0.76 | - | -1.59 | -1.99 |
| Diluted Earnings Per Share |
15.79%
-0.64
|
-0.76 | - | -1.59 | -1.99 |
자본화:
|
볼륨(24시간):